Skip to : [Content] [Navigation]
Medical Product Manufacturing News
 

Archive for August, 2009

Silk Serves as Base for Nanoparticle Composites

Wednesday, August 26th, 2009
An atomic force microscope image shows a silk film on which gold nanoparticles were grown. Image: Georgia Tech

An atomic force microscope image shows a silk film on which gold nanoparticles were grown. Image: Georgia Tech

Researchers at the Georgia Institute of Technology (Atlanta) have produced strong and flexible nanometer-scale composite films by combining silk with metallic particles. Boasting unusual mechanical and optical properties, the synthetic material could be used in future medical technologies and antimicrobial films.

The fabrication process uses silk as a template. First, the researchers dissolved silk cocoons and placed the resulting material onto a silicon substrate using a spin-coating method. The newly created multilayer film is then patterned into a template by employing a nanolithography technique and subsequently immersed in a solution containing metal ions such as silver or gold. “Because silk is a protein, we can control the properties of the surface and design different kinds of surfaces,” explains Eugenia Kharlampieva, a postdoctoral researcher. “This surface-mediated approach is flexible at producing different shapes. We can apply the method to coat any surface we want, including objects of complex shapes.”

Once placed in the solution, the template facilitates nanoparticle formation. Occurring in a room-temperature, neutral-pH, water-based environment, nanoparticle growth can be precisely controlled in terms of particle size and spacing, according to the researchers. The silk-nanoparticle film features equally dispersed particles that remain separate; optical properties of the film are determined by nanoparticle material and size. It is characterized by high tensile strength, high elasticity, and toughness. The scientists maintain that such a process could reduce associated production costs and environmental impact.

Free MPMN Webcast Highlights Biomaterials for Implantable Devices

Tuesday, August 25th, 2009

Patients who have ever had a knee implant or worn a catheter know firsthand how implantable medical devices have become a way of life for millions. But what makes such devices compatible with the human body? How do device makers ensure that the implants they market will not be rejected by the body’s immune system? In this Webcast, “Biocompatible Polymers for Implantable Medical Device Applications,” panelists specializing in the science and technology of biocompatible polymer materials for implantable medical device applications will focus on materials, material structures, biointegration, and bioresorbability. The Webcast is hosted by Medical Product Manufacturing News and cosponsored by Biomedical Structures LLC and AdvanSource Biomaterials. Biomedical Structures is a contract medical device manufacturer that uses resorbable and nonresorbable fibers to manufacture braids, knits, and woven and nonwoven structures for medical device applications. AdvanSource Biomaterials is a leading materials technology company that provides thermoplastic polycarbonates, aromatic and aliphatic ether-based polyurethanes, extrudable hydrophilics, antimicrobial product lines, and specialized coatings specifically tailored to optimize customers’ device characteristics.

Register now for the free live Webcast slated for Wednesday, August 26, 2009, at 11 am PST/ 2 pm EST.

Speakers include:
Arikha Moses, Chief Scientific Officer, TYRX Inc.
Tyrosine-Derived Polyesteramides: Novel Resorbable Polymers for Combination Products

Scott DeFelice, President & CEO, Oxford Performance Materials
PEKK: Rigid and Flexible Polymer System for Long-Term Implants

Max Maginness, CTO, Healionics Corp.
Biointegrating Materials: Going Beyond Biocompatibility

Orthopedics Hub Rides Out Recession

Tuesday, August 25th, 2009

Indiana is the place to be for orthopedic device manufacturers.

Indiana is the place to be for orthopedic device manufacturers.

The Indianapolis Star recently reported that, despite the turbulent economic environment, orthopedic device manufacturers in the state appear to be holding steady. And if there’s any region that can act as a barometer for the orthopedics sector, it’s the Hoosier state. After all, three of the Top-10 orthopedics manufacturers call the state— and even more specifically, the city of Warsaw—home, as do a variety of suppliers and smaller medical device OEMs.

Accounting for roughly a quarter of all jobs in Warsaw’s Kosciusko County, the orthopedics and life sciences industries continue to dominate the area, despite mounting obstacles. Stymied by FDA turnover and potential healthcare reform, the area’s manufacturers are somewhat nervous about what the future may hold, the newspaper reports. Such change could slow down time to market and force OEMs to reduce prices, for example. And, although companies are staying afloat better than those in various other industries, they are experiencing setbacks from the recession as the uninsured opt to delay nonemergency surgeries such as joint replacements. But despite some slipping revenue, the companies seem to be optimistic that they will ride out the recession by maintaining if not gaining.

Read more about The Orthopedics Capital of the World, Warsaw, Indiana, and its role in the medtech industry from the pages of MPMN.

Nanostructure Engineering May Benefit Medical Coatings Applications

Monday, August 24th, 2009

Researchers at the State Key Laboratory of Electroanalytical Chemistry at the Chinese Academy of Sciences (CAS; Beijing) have demonstrated the potential of using biofilms for nanostructure engineering. Describing the use of biofilms as engineering materials for nanostructures and demonstrating it using zinc oxide nanorods, the scientists says that since biofilms are gel-like matrices that can be adhered on several substrates, such bilateral adhesive behavior can be employed to immobilize the nanostructures on various types of substrates. Because of the material’s excellent biocompatibility, this strategy can perhaps be marshaled to produce medical coatings and other biomedical products.

While biofilms are generally viewed as pathogenic threats, their complex frameworks, biological behavior, chemical heterogeneity, and physical structure at the micro- and the nanoscale can also be useful in nanofabrication.

Led by Xiurong Yang, a professor at the Changchun Institute of Applied Chemistry, the researchers present strategies that can be applied to the immobilization, fabrication, and organization of nanostructures as long as they can be prepared in an aqueous solution and the precursors can react with a bacterium. Their research shows that biofilms can be an efficient and low-cost approach for large-scale fabrication of various nanostructures.

Using the example of zinc oxide nanostructures, the CAS team explored the use of biofilms in three aspects: immobilization, morphological organization, and selective permeability. They began with the fermentation of Streptococcus thermophilus, a lactic acid bacterium. They then used the resulting biofilm to immobilize zinc oxide nanorods on a polystyrene substrate with a curved surface (the inner wall of a centrifuge tube). These as-grown zinc oxide nanostructures remained quite stable after irradiation sterilization. This technique also worked on other substrates, such as glass, silicon, and indium tin oxide.

“The ingenious structure of biofilms can lead to the synthesis of fantastic nanostructure devices, even beyond the fabrication capability of the current state-of-the-art methods,” the authors say.

Glenbrook Technologies Honored by New Jersey Inventors Hall of Fame

Friday, August 21st, 2009

The New Jersey Inventors Hall of Fame has bestowed the Invention Advancement Award for 2009 on Glenbrook Technologies Inc. (Randolph, NJ), a company specializing in x-ray technology. Honoring individuals or organizations in New Jersey that contribute to positive advancements for the improvement of people’s lives, the award acknowledges Glenbrook’s x-ray technology, “which produces highly magnified fluoroscopic images that reveal tiny anatomical details, and displays them on a video monitor in full motion, using very low levels of radiation,” according to Glenbrook. The company maintains that this capability is not currently available in any other radiological imaging modalities, including angiography, digital radiography, MRI, CT, PET or SPET. It is employed by numerous medical device manufacturers to ensure medical implant quality.

Gil Zweig, founder and president of Glenbrook Technologies, was previously honored by the organization, earning the title of Inventor of the Year in 1994. In addition, the company was honored with a Life Sciences Award in 2007 presented by the New Jersey Technical Council.

Read more about Glenbrook Technologies and the innovation stemming from the New Jersey medtech industry in general in a Regional Focus on the Garden State from the pages of MPMN.

University, Manufacturer Team Up to Supply Implantable Biogenerators

Thursday, August 20th, 2009

The University of Colorado has granted an option to Biotricity Medical Inc. to develop technology for implantable biogenerators. Providing a long-term, potentially inexhaustible power supply for implantable medical devices such as pacemakers and insulin pumps, the bioregenerators remove the need for repeated surgeries to replace power supplies.

The company’s first planned product, EpiVolt, is a tiny implantable biogenerator that will provide power to pacemakers, insulin pumps, cochlear implants, artificial retinas, and vagal nerve stimulators. The device is made of living electricity-generating cells that use the body’s own natural chemicals and processes to create electric power.

“It’s an inexhaustible source of power that will be much smaller than the batteries it will replace,” explains Simon Rock Levinson, professor of physiology and biophysics at the university’s school of medicine. “This will allow the EpiVolt to be permanently implanted in very small spaces along with the device that it powers, without the need for long connecting wires running through the body to a remote battery power source.” The company believes its products will improve the quality of life for millions of people with diabetes, chronic pain, and Parkinson’s disease, in addition helping those with pacemakers, cochlear implants and other implanted devices.

“If the EpiVolt proves to be scalable and commercially feasible, it can be a powerful platform for miniaturisation, expand design flexibility, and push back the practical limitations for implantable electronic medical devices,” remarks Rick Silva, director of technology transfer for the University. “We have been impressed by the technical challenges already addressed and are optimistic about demonstrating the feasibility of the technology in animals in the relatively near future.”

Bonding with Sea Worms

Wednesday, August 19th, 2009

Scientists have created a glue derived from a marine worm that could help surgeons repair shattered bones. The team of U.S. researchers hopes that the adhesive will eventually replace the metal wires, pins, and screws used to hold bone fragments in place. While avoiding metal hardware in the body, glue would also make it easier to fasten small bone fragments.

To create the material, the scientists copied a natural glue secreted by the sandcastle worm, or Phragmatopoma californica, an organism that uses the glue to bond sand grains and seashell fragments together to build a protective dwelling. Strong and impervious to water, the biodegradable adhesive sets in response to changes in acidity, just like the natural glue on which it is based.

“We recognized that the mechanism used by the sandcastle worm is really a perfect vehicle for producing an underwater adhesive,” remarks team leader Russell Stewart from the University of Utah (Salt Lake City). “This glue, just like the worm’s glue, is a fluid material that, although it doesn’t mix with water, is water soluble.”

The team has launched pilot studies to determine how to deliver bioactive molecules within the glue, including antibiotics, pain relievers, and compounds for accelerating healing.

“Biocompatibility is one of the major challenges of creating an adhesive like this,” Stewart says. “Anytime you put something synthetic into the body, there’s a chance the body will respond to it and damage the surrounding tissue. That’s something we will monitor, but we’ve seen no indication right now that it will be a problem.”

European Project Lends Nanotechnology a Hand

Tuesday, August 18th, 2009

There are perhaps few words in the medtech industry currently more buzz-worthy than ‘nanotechnology.’ After all, the field promises revolutionary advancements in seemingly every aspect of the medical industry. But among the many challenges impeding commercialization of nanotechnology-enabled products is the lack of nanomanufacturing methods for production. NanoHand, a European-funded project, aims to change that.

The collaborative effort seeks to “create the world’s first nanorobotic production system inside of a scanning electron microscope (SEM).” Doing so, the group states, will enable the automatic handling and manipulation of carbon nanotubes in order to yield innovative new devices or replace macroscale components in existing device designs.The consortium has already made progress on this front with the NanoLab. Featuring tiny robots wielding electrothermal microgrippers within an SEM, the NanoLab enables nanohandling, which the group breaks down into three subsequences: carbon nanotube indexing, picking up a carbon nanotube, and placing a carbon nanotube. Watch the below video for a demonstration of the NanoLab’s capabilities.

Carbon Nanocapsules Hold Promise for Future Drug-Delivery and Imaging Applications

Monday, August 17th, 2009

Chemistry professors Alexander Star and Stéphane Petoud at the University of Pittburgh have developed nanosized capsules using carbon nanomaterials that may one day enhance technologies for delivering drugs or imaging agents to the body. With the aid of antibodies and biological molecules, the devices may also be able to target specific locations within the human body.

The scientists have used carbon nanomaterials to create enhanced versions of existing technologies. Existing technologies are typically constructed of polymers that are permeable like a sponge and can result in leakage, Star explains. Additionally, each capsule must be tailored to its particular cargo. Star and Petoud’s invention employs graphite carbon shells bonded with glutaraldehyde—a common biological adhesive—to create a hollow storage space. Since the graphite shells are chemically inactive, they are compatible with any cargo substance without having to undergo costly and time-consuming chemical preparation, Star adds.

To illustrate the capsules’ adaptability, the team loaded them with a luminescent imaging agent made of zinc sulfide semiconductor nanocrystals incorporating terbium, a metal that is chemically similar to europium. Once in the body, this substance would emit a unique light that allows easier detection and better imaging, Petoud comments. While inorganic nanocrystals have to be prepared before being introduced to a biological environment such as the body, the graphite nanocapsules can hold and transport the solution without preparation.

“For decades, researchers have been searching for an optimal vessel for storing and transporting a variety of cargo to specified locations,” Star remarks. “Our devices have the potential to be universal delivery vehicles for a range of materials. Our next steps will focus on controlling how and when the nanocapsules open by using different stimuli such as pH, light, and chemical agents.”

Sil-Pro Expands Extrusion Capabilities

Friday, August 14th, 2009
New systems enhance Sil-Pro's extrusion offerings to the medical device industry.

New systems enhance Sil-Pro's extrusion offerings to the medical device industry.

Sil-Pro Silicone Professionals (Delano MN) has added systems to its plant in order to provide expanded extrusion capabilities. With the the new systems, the ISO 9001:2000–certified company can offer in-line, close-tolerance cutting of silicone tubing directly from the extrusion machine. Single-lumen, multilumen, solid-rope, and rod silicone tubing can be provided with inner and outer diameters ranging from 0.02 to 1.0 in. In addition to extruding silicone tubing, the company can overmold onto silicone tubes, bond singular tubular parts to plastic and metal components using medical-grade adhesives, and pad-print identification marks onto silicone tubing for positioning or lot traceability. Tube color options include clear, translucent, opaque, and colored versions.

“Our new capabilities will give customers a boost with accelerated time-to-market projects and provide many cost-effective benefits,” says Brian Higgins, Sil-Pro vice president of sales and marketing. “We continue to expand our facilities with new technology to provide medical device companies with the quality and turnaround time they require.”